drugset / Trial / NCT04709770

Low-volume vs High-volume Polyethylene Glycol Based Bowel Preparation for Colonoscopy in People Receiving Hemodialysis

NCT04709770 ↗

Phase 4 Unknown 264 enrolled Alfredo Di Leo Alfasigma S.p.A. · collab
RandomizedParallel-groupSingle-blindTreatment

Summary

Current American Society for Gastrointestinal Endoscopy (ASGE) and European Society of Gastrointestinal Endoscopy (ESGE) guidelines recommend a split regimen of high-volume (4-liter polyethylene glycol-based preparation) or low-volume (2-liter polyethylene glycol-based solutions or sodium picosulphate plus magnesium citrate) formulations for routine bowel preparation. Some concerns have been raised about the use of oral bowel-cleansing agents in people receiving hemodialysis due to the possibility of secondary intravascular depletion. There is a risk for thrombosis of dialysis access in case of hypotension. The association of hemodialysis treatment and the use of bowel preparations may induce severe hypovolaemia. Finally, the 4-liter intake with high-volume preparations may cause fluid overload in anuric patients. The aim of our study will be to assess in a randomized trial the non-inferiority of a low-volume versus a high-volume polyethylene glycol-based bowel preparation for adequate bowel cleansing in people receiving hemodialysis (primary end-point). We will also compare the low-volume versus the high-volume preparation for other endoscopic and nephrologic relevant clinical outcomes (secondary end-points).

Timeline

Start
2021-02-01
Primary completion
2022-03-01
Completion
2022-03-01

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject polyethylene glycol with citrate and simethicone Unknown 2000 ml Oral
Comparator polyethylene glycol with simethicone Unknown 4000 ml Oral